Pure Bio Medical Jiangsu Ltd.

We are NJCTTQ (Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.), a member company of Sino Biopharm (1177.HK) — a Global Top 50 pharma company.

We operate our own API manufacturing facility (Pure Bio Medical Jiangsu Ltd.) in Nanjing. Construction began in 2019, and the site became fully operational in 2025. Built and maintained under EU GMP and ICH Q7 standards, it has a proven track record supplying our in-house formulations. Leveraging this quality foundation, we are now expanding into Europe, with 2 CEP filings planned this year and more molecules in the pipeline.